Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. This Business Profile tracks the Brand Authority Index and supporting AI visibility evidence. Last analyzed September 19, 2026.
Cannformatics delivers predictable and repeatable science-based medical cannabis outcomes to improve health and quality of life. The company uses proprietary Cannabis-Responsive™ (C-Res™) biomarker technology and an AI-powered cannabinoid-based pharmacometabolomics approach to personalize medical cannabis treatment, focusing initially on neurological and neuropsychiatric disorders like autism and dementia.
AI did not recommend this brand in the limited public category test.
Optimly has not yet published a supported competitor set for Cannformatics.
Brand Authority Index (BAI) tier: Emerging (exact score locked for unclaimed brands)
Official website: https://cannformatics.com/
Last analyzed: September 19, 2026
This Business Profile is published by Optimly in the Optimly AI Brand Index, a public research dataset showing how AI systems describe brands, categories, and competitors. Optimly AI Visibility analyzes sampled buyer-intent responses, cited sources, and public brand information. The Brand Authority Index summarizes answer presence, narrative accuracy, and owned citations where sufficient evidence is available.
If this is your brand, you can claim this profile to verify its contents and correct what AI models say about you: Claim this profile